| 1 | Cancer | 2.43% | |
| 2 | Study | 1.74% | |
| 3 | Risk | 1.04% | |
| 4 | May | 1.04% | |
| 5 | Prostate | 1.04% | |
| 6 | Stage | 1.04% | |
| 7 | Health | 0.69% | |
| 8 | Colon | 0.69% | |
| 9 | Sleep | 0.69% | |
| 10 | Patient | 0.69% | |
| 11 | Plus | 0.69% | |
| 12 | Plaque | 0.69% | |
| 13 | III | 0.69% | |
| 14 | NSS | 0.69% | |
| 15 | Treatment | 0.69% | |
| 16 | Advanced | 0.69% | |
| 17 | Patients | 0.69% | |
| 18 | Improved | 0.69% | |
| 19 | Time | 0.69% | |
| 20 | Report | 0.69% | |
| 21 | Melanoma | 0.69% | |
| 22 | ASCO | 0.69% | |
| 23 | Tea | 0.69% | |
| 24 | Retrospective | 0.69% | |
| 25 | NSCLC | 0.69% | |
| 26 | Chemo | 0.69% | |
| 27 | OS | 0.69% | |
| 28 | Taiwan | 0.69% | |
| 29 | Survival | 0.69% | |
| 30 | Focus | 0.35% | |
| 31 | Dilated | 0.35% | |
| 32 | Bird | 0.35% | |
| 33 | Non-Medical | 0.35% | |
| 34 | Influenza | 0.35% | |
| 35 | DCM | 0.35% | |
| 36 | Beriberi | 0.35% | |
| 37 | Nivolumab | 0.35% | |
| 38 | Signs | 0.35% | |
| 39 | CD30 | 0.35% | |
| 40 | Overall | 0.35% | |
| 41 | Affinia | 0.35% | |
| 42 | Day | 0.35% | |
| 43 | Convergence | 0.35% | |
| 44 | Neoadjuvant | 0.35% | |
| 45 | Syndrome | 0.35% | |
| 46 | Often | 0.35% | |
| 47 | Drug | 0.35% | |
| 48 | Healthcare | 0.35% | |
| 49 | PSMA | 0.35% | |
| 50 | Need | 0.35% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||